Scotland-based biotech Invizius has completed a Phase I clinical study, assessing its dialysis priming product H-Guard. H-Guard is a specialised medical device coating indicated for use in dialysis ...

The pre-dialysis check is not a time to just look at the circuit and confirm that it is 'connected.' It is a process to ...

Invizius estimates that about 20% of dialysis patients may have "angry blood," where an overzealous inflammatory response can lead to serious complications. ((Getty/Mailson Pignata)) Invizius has ...

Scottish biotech firm Invizius, which has developed a technology aimed at reducing long-term side effects and health complications from dialysis treatment, is seeking Series A funding after undergoing ...